• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于心肌T1和ECV映射质量控制的磁共振成像体模:特定配方、长期稳定性以及随心率和温度的变化

Magnetic resonance imaging phantoms for quality-control of myocardial T1 and ECV mapping: specific formulation, long-term stability and variation with heart rate and temperature.

作者信息

Vassiliou Vassilios S, Heng Ee Ling, Gatehouse Peter D, Donovan Jacqueline, Raphael Claire E, Giri Shivraman, Babu-Narayan Sonya V, Gatzoulis Michael A, Pennell Dudley J, Prasad Sanjay K, Firmin David N

机构信息

NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, Sydney Street, London, SW3 6NP, UK.

Imperial College, National Heart and Lung Institute, London, UK.

出版信息

J Cardiovasc Magn Reson. 2016 Sep 22;18(1):62. doi: 10.1186/s12968-016-0275-9.

DOI:10.1186/s12968-016-0275-9
PMID:27659737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5034463/
Abstract

BACKGROUND

Magnetic resonance imaging (MRI) phantoms are routinely used for quality assurance in MRI centres; however their long term stability for verification of myocardial T1/ extracellular volume fraction (ECV) mapping has never been investigated.

METHODS

Nickel-chloride agarose gel phantoms were formulated in a reproducible laboratory procedure to mimic blood and myocardial T1 and T2 values, native and late after Gadolinium administration as used in T1/ECV mapping. The phantoms were imaged weekly with an 11 heart beat MOLLI sequence for T1 and long TR spin-echo sequences for T2, in a carefully controlled reproducible manner for 12 months.

RESULTS

There were only small relative changes seen in all the native and post gadolinium T1 values (up to 9.0 % maximal relative change in T1 values) or phantom ECV (up to 8.3 % maximal relative change of ECV, up to 2.2 % maximal absolute change in ECV) during this period. All native and post gadolinium T2 values remained stable over time with <2 % change. Temperature sensitivity testing showed MOLLI T1 values in the long T1 phantoms increasing by 23.9 ms per degree increase and short T1 phantoms increasing by 0.3 ms per degree increase. There was a small absolute increase in ECV of 0.069 % (0.22 % relative increase in ECV) per degree increase. Variation in heart rate testing showed a 0.13 % absolute increase in ECV (0.45 % relative increase in ECV) per 10 heart rate increase.

CONCLUSIONS

These are the first phantoms reported in the literature modeling T1 and T2 values for blood and myocardium specifically for the T1mapping/ECV mapping application, with stability tested rigorously over a 12 month period. This work has significant implications for the utility of such phantoms in improving the accuracy of serial scans for myocardial tissue characterisation by T1 mapping methods and in multicentre work.

摘要

背景

磁共振成像(MRI)体模常用于MRI中心的质量保证;然而,其用于验证心肌T1/细胞外容积分数(ECV)成像的长期稳定性从未得到研究。

方法

采用可重复的实验室程序制备氯化镍琼脂糖凝胶体模,以模拟血液和心肌的T1和T2值,即T1/ECV成像中钆剂注射前后的数值。每周使用11心动周期MOLLI序列对体模进行T1成像,使用长TR自旋回波序列进行T2成像,以精心控制的可重复方式持续12个月。

结果

在此期间,所有钆剂注射前后的T1值(T1值最大相对变化高达9.0%)或体模ECV(ECV最大相对变化高达8.3%,ECV最大绝对变化高达2.2%)仅有微小的相对变化。所有钆剂注射前后的T2值随时间保持稳定,变化<2%。温度敏感性测试显示,长T1体模的MOLLI T1值每升高1度增加23.9毫秒,短T1体模每升高1度增加0.3毫秒。ECV每升高1度有0.069%的微小绝对增加(ECV相对增加约0.22%)。心率变化测试显示,心率每增加10次,ECV有0.13%的绝对增加(ECV相对增加约0.45%)。

结论

这是文献中首次报道的专门用于T1成像/ECV成像应用、模拟血液和心肌T1和T2值的体模,并在12个月期间进行了严格的稳定性测试。这项工作对于此类体模在提高T1成像方法对心肌组织特征进行系列扫描的准确性以及在多中心研究中的应用具有重要意义。

相似文献

1
Magnetic resonance imaging phantoms for quality-control of myocardial T1 and ECV mapping: specific formulation, long-term stability and variation with heart rate and temperature.用于心肌T1和ECV映射质量控制的磁共振成像体模:特定配方、长期稳定性以及随心率和温度的变化
J Cardiovasc Magn Reson. 2016 Sep 22;18(1):62. doi: 10.1186/s12968-016-0275-9.
2
A medical device-grade T1 and ECV phantom for global T1 mapping quality assurance-the T Mapping and ECV Standardization in cardiovascular magnetic resonance (T1MES) program.用于全球T1映射质量保证的医疗设备级T1和ECV体模——心血管磁共振成像中的T映射与ECV标准化(T1MES)项目
J Cardiovasc Magn Reson. 2016 Sep 22;18(1):58. doi: 10.1186/s12968-016-0280-z.
3
Myocardial T-mapping at 3T using saturation-recovery: reference values, precision and comparison with MOLLI.使用饱和恢复法在3T下进行心肌T值映射:参考值、精密度及与MOLLI的比较
J Cardiovasc Magn Reson. 2016 Nov 18;18(1):84. doi: 10.1186/s12968-016-0302-x.
4
Cardiac stress T1-mapping response and extracellular volume stability of MOLLI-based T1-mapping methods.基于 MOLLI 的 T1 映射方法的心脏应激 T1 映射反应和细胞外容积稳定性。
Sci Rep. 2021 Jun 30;11(1):13568. doi: 10.1038/s41598-021-92923-4.
5
Free-breathing, non-ECG, continuous myocardial T mapping with cardiovascular magnetic resonance multitasking.自由呼吸、非心电图、连续心肌 T 映射与心血管磁共振多任务处理。
Magn Reson Med. 2019 Apr;81(4):2450-2463. doi: 10.1002/mrm.27574. Epub 2018 Nov 19.
6
Developing a medical device-grade T phantom optimized for myocardial T mapping by cardiovascular magnetic resonance.开发一种心血管磁共振用的、适用于心肌 T 映射的医疗设备级 T phantom。
J Cardiovasc Magn Reson. 2023 Mar 20;25(1):19. doi: 10.1186/s12968-023-00926-z.
7
Age and sex corrected normal reference values of T1, T2 T2* and ECV in healthy subjects at 3T CMR.3T CMR 健康受试者 T1、T2、T2* 和 ECV 的年龄和性别校正正常参考值。
J Cardiovasc Magn Reson. 2017 Sep 21;19(1):72. doi: 10.1186/s12968-017-0371-5.
8
Prognostic Value of Myocardial Extracellular Volume Fraction and T2-mapping in Heart Transplant Patients.心肌细胞外容积分数和 T2-mapping 在心脏移植患者中的预后价值。
JACC Cardiovasc Imaging. 2020 Jul;13(7):1521-1530. doi: 10.1016/j.jcmg.2020.01.014. Epub 2020 Mar 18.
9
T1 and T2 mapping cardiovascular magnetic resonance imaging techniques reveal unapparent myocardial injury in patients with myocarditis.T1和T2映射心血管磁共振成像技术可揭示心肌炎患者隐匿的心肌损伤。
Clin Res Cardiol. 2017 Jan;106(1):10-17. doi: 10.1007/s00392-016-1018-5. Epub 2016 Jul 7.
10
Association between myocardial hypoxia and fibrosis in hypertrophic cardiomyopathy: analysis by T2* BOLD and T1 mapping MRI.肥厚型心肌病中心肌缺氧与纤维化的相关性:T2* 弛豫时间对比增强磁共振和 T1 mapping 分析。
Eur Radiol. 2020 Aug;30(8):4327-4336. doi: 10.1007/s00330-020-06779-9. Epub 2020 Mar 24.

引用本文的文献

1
Association between Long-term Exposure to Ambient Air Pollution and Myocardial Fibrosis Assessed with Cardiac MRI.长期暴露于环境空气污染与通过心脏磁共振成像评估的心肌纤维化之间的关联。
Radiology. 2025 Jul;316(1):e250331. doi: 10.1148/radiol.250331.
2
A straightforward procedure to build a non-toxic relaxometry phantom with desired T1 and T2 times at 3T.一种在 3T 下构建具有所需 T1 和 T2 弛豫时间的无毒弛豫率体的简单方法。
MAGMA. 2024 Oct;37(5):899-907. doi: 10.1007/s10334-024-01166-7. Epub 2024 May 11.
3
A novel cardiovascular magnetic resonance risk score for predicting mortality following surgical aortic valve replacement.

本文引用的文献

1
Gibbs-ringing artifact removal based on local subvoxel-shifts.基于局部亚体素移位的吉布斯振铃伪影去除
Magn Reson Med. 2016 Nov;76(5):1574-1581. doi: 10.1002/mrm.26054. Epub 2015 Nov 24.
2
Adenosine Stress and Rest T1 Mapping Can Differentiate Between Ischemic, Infarcted, Remote, and Normal Myocardium Without the Need for Gadolinium Contrast Agents.腺苷负荷与静息状态下的T1映射无需钆对比剂即可区分缺血、梗死、远隔和正常心肌。
JACC Cardiovasc Imaging. 2016 Jan;9(1):27-36. doi: 10.1016/j.jcmg.2015.08.018. Epub 2015 Dec 9.
3
T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
一种新的心血管磁共振风险评分,用于预测主动脉瓣置换术后的死亡率。
Sci Rep. 2021 Oct 12;11(1):20183. doi: 10.1038/s41598-021-99788-7.
4
Extracellular volume fraction by T1 mapping predicts improvement of left ventricular ejection fraction after catheter ablation in patients with non-ischemic dilated cardiomyopathy and atrial fibrillation.T1 mapping 测量的细胞外容积分数可预测非缺血性扩张型心肌病伴心房颤动患者经导管消融治疗后左心室射血分数的改善。
Int J Cardiovasc Imaging. 2021 Aug;37(8):2535-2543. doi: 10.1007/s10554-021-02219-x. Epub 2021 Mar 16.
5
Rapid multicontrast brain imaging on a 0.35T MR-linac.在0.35T磁共振直线加速器上进行快速多对比度脑成像。
Med Phys. 2020 Sep;47(9):4064-4076. doi: 10.1002/mp.14251. Epub 2020 Jul 6.
6
T mapping performance and measurement repeatability: results from the multi-national T mapping standardization phantom program (T1MES).T 映射性能与测量重复性:多国 T 映射标准化体模程序(T1MES)的结果
J Cardiovasc Magn Reson. 2020 May 7;22(1):31. doi: 10.1186/s12968-020-00613-3.
7
Z-score mapping for standardized analysis and reporting of cardiovascular magnetic resonance modified Look-Locker inversion recovery (MOLLI) T1 data: Normal behavior and validation in patients with amyloidosis.Z 分数映射用于心血管磁共振改良 Look-Locker 反转恢复(MOLLI)T1 数据的标准化分析和报告:淀粉样变性患者的正常表现和验证。
J Cardiovasc Magn Reson. 2020 Jan 20;22(1):6. doi: 10.1186/s12968-019-0595-7.
8
Repeatability and reproducibility of longitudinal relaxation rate in 12 small-animal MRI systems.12 个小动物 MRI 系统中纵向弛豫率的可重复性和再现性
Magn Reson Imaging. 2019 Jun;59:121-129. doi: 10.1016/j.mri.2019.03.008. Epub 2019 Mar 12.
9
Journal of Cardiovascular Magnetic Resonance 2017.《心血管磁共振杂志》 2017 年刊
J Cardiovasc Magn Reson. 2018 Dec 28;20(1):89. doi: 10.1186/s12968-018-0518-z.
10
Review of Journal of Cardiovascular Magnetic Resonance (JCMR) 2015-2016 and transition of the JCMR office to Boston.回顾《心血管磁共振杂志》(JCMR)2015-2016 年的出版情况以及该杂志办公室迁至波士顿的情况。
J Cardiovasc Magn Reson. 2017 Dec 28;19(1):108. doi: 10.1186/s12968-017-0423-x.
T1 Mapping在肥厚型表型鉴别中的应用:高血压性心脏病和肥厚型心肌病:国际T1多中心心血管磁共振研究结果
Circ Cardiovasc Imaging. 2015 Dec;8(12). doi: 10.1161/CIRCIMAGING.115.003285.
4
T1 at 1.5T and 3T compared with conventional T2* at 1.5T for cardiac siderosis.在心脏铁沉积方面,1.5T和3T下的T1与1.5T下的传统T2*对比。
J Cardiovasc Magn Reson. 2015 Nov 24;17:102. doi: 10.1186/s12968-015-0207-0.
5
Native T1 Mapping by 3-T CMR Imaging for Characterization of Chronic Myocardial Infarctions.3T CMR 成像的心肌固有 T1 映射用于慢性心肌梗死的特征描述。
JACC Cardiovasc Imaging. 2015 Sep;8(9):1019-1030. doi: 10.1016/j.jcmg.2015.04.018. Epub 2015 Aug 19.
6
Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR.利用心脏磁共振成像对临床诊断为心肌炎的患者进行急性期与恢复期的鉴别诊断:一种新的诊断算法。
JACC Cardiovasc Imaging. 2015 Jan;8(1):37-46. doi: 10.1016/j.jcmg.2014.07.016. Epub 2014 Dec 10.
7
Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance.天然心肌T1映射在法布里病评估中的可重复性及其在心血管磁共振早期检测心脏受累中的作用。
J Cardiovasc Magn Reson. 2014 Dec 5;16(1):99. doi: 10.1186/s12968-014-0099-4.
8
T1-mapping in the heart: accuracy and precision.心脏 T1-mapping:准确性和精密度。
J Cardiovasc Magn Reson. 2014 Jan 4;16(1):2. doi: 10.1186/1532-429X-16-2.
9
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement.心肌 T1 映射和细胞外容积定量:心血管磁共振学会 (SCMR) 和欧洲心脏病学会 CMR 工作组的共识声明。
J Cardiovasc Magn Reson. 2013 Oct 14;15(1):92. doi: 10.1186/1532-429X-15-92.
10
Standardization of T1 measurements with MOLLI in differentiation between health and disease--the ConSept study.MOLLI 测量 T1 值在健康与疾病鉴别诊断中的标准化——ConSept 研究。
J Cardiovasc Magn Reson. 2013 Sep 11;15(1):78. doi: 10.1186/1532-429X-15-78.